BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 14752307)

  • 1. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
    Rishi K; Font RL
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome.
    Font RL; Rishi K
    Ophthalmology; 2003 Sep; 110(9):1833-6. PubMed ID: 13129885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases.
    Demirci H; Nelson CC; Shields CL; Eagle RC; Shields JA
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):77-9. PubMed ID: 17237705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
    Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
    Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebaceous adenomas of the eyelid and Muir-Torre Syndrome.
    Jagan L; Zoroquiain P; Bravo-Filho V; Logan P; Qutub M; Burnier MN
    Br J Ophthalmol; 2015 Jul; 99(7):909-13. PubMed ID: 25595178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sebaceous gland adenoma of the palpebral conjunctiva in a patient with Muir-Torre-syndrome: a case report.
    Meier-Gibbons F; Messmer E
    Graefes Arch Clin Exp Ophthalmol; 1994 Dec; 232(12):734-6. PubMed ID: 7890187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.
    Rütten A; Burgdorf W; Hügel H; Kutzner H; Hosseiny-Malayeri HR; Friedl W; Propping P; Kruse R
    Am J Dermatopathol; 1999 Oct; 21(5):405-13. PubMed ID: 10535567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.
    Machin P; Catasus L; Pons C; Muñoz J; Conde-Zurita JM; Balmaña J; Barnadas M; Martí RM; Prat J; Matias-Guiu X
    J Cutan Pathol; 2002 Aug; 29(7):415-20. PubMed ID: 12139636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sebaceous tumors of the eyelids in a patient with Muir-Torre syndrome].
    Bertholom JL; Guyomard JL; Stock N; Dugast C; Martinel C; Chatel MA; Charlin JF
    J Fr Ophtalmol; 2006 Jun; 29(6):654-8. PubMed ID: 16885896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
    J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.
    Neelakantan IV; Di Palma S; Smith CE; McCoombe A
    Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sebaceous adenoma of the eyelid in Muir-Torre syndrome.
    Singh AD; Mudhar HS; Bhola R; Rundle PA; Rennie IG
    Arch Ophthalmol; 2005 Apr; 123(4):562-5. PubMed ID: 15824235
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
    Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
    J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of mismatch repair proteins in sebaceous gland tumors.
    Popnikolov NK; Gatalica Z; Colome-Grimmer MI; Sánchez RL
    J Cutan Pathol; 2003 Mar; 30(3):178-84. PubMed ID: 12641777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sebaceous Neoplasms.
    Flux K
    Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muir-Torre Syndrome in a Middle-Aged Chinese Patient with Sebaceous Carcinoma of the Eyelid.
    Wong CY; Tang RK; Lam RF; Io IY; Yuen CY; Ho JW; Tse RK
    Semin Ophthalmol; 2015; 30(5-6):420-2. PubMed ID: 24117411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraocular well-differentiated sebaceous tumors with overlying cutaneous horns: four tumors in three patients.
    Jhuang JY; Liao SL; Tsai JH; Chang HC; Kuo KT; Liau JY
    J Cutan Pathol; 2014 Aug; 41(8):650-6. PubMed ID: 24548110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.